8-Demethoxycephatonine

CAS No. 1457991-80-8

8-Demethoxycephatonine( ——— )

Catalog No. M38110 CAS No. 1457991-80-8

8-Demethoxycephatonine is an isoquinoline alkaloid, that can be isolated from Sinomenium acutum (Menispermaceae).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    8-Demethoxycephatonine
  • Note
    Research use only, not for human use.
  • Brief Description
    8-Demethoxycephatonine is an isoquinoline alkaloid, that can be isolated from Sinomenium acutum (Menispermaceae).
  • Description
    8-Demethoxycephatonine is an isoquinoline alkaloid, that can be isolated from Sinomenium acutum (Menispermaceae).
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1457991-80-8
  • Formula Weight
    329.39
  • Molecular Formula
    C19H23NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lee JY, et al. Anti-osteoclastogenic effects of isoquinoline alkaloids from the rhizome extract of Sinomenium acutum. Arch Pharm Res. 2016 May;39(5):713-20. ?
molnova catalog
related products
  • Phenylpropiolic acid

    Phenylpropiolic acid is an endogenous metabolite.

  • SBE-β-CD

    SBE-β-CD is a sulfobutylether β-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE).

  • Soyasaponin Aa

    Soyasaponin Aa and soyasaponin Ab dose-dependently markedly inhibit adipocyte differentiation and expression of various adipogenic marker genes, through the downregulation of the adipogenesis-related transcription factors PPARγ and C/EBPα± in 3T3-L1 adipocytes.